BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3748324)

  • 1. 5-Hydroxytryptamine-mediated behaviour in male and female rats.
    Dickinson SL; Curzon G
    Neuropharmacology; 1986 Jul; 25(7):771-6. PubMed ID: 3748324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
    Rényi L
    Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.
    Adell A; Sarna GS; Hutson PH; Curzon G
    Br J Pharmacol; 1989 May; 97(1):206-12. PubMed ID: 2720308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour.
    Dickinson SL; Curzon G
    Neuropharmacology; 1983 Jul; 22(7):805-12. PubMed ID: 6225959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced-5-hydroxytryptamine-dependent behavior in rats following chronic corticosterone treatment.
    Dickinson SL; Kennett GA; Curzon G
    Brain Res; 1985 Oct; 345(1):10-8. PubMed ID: 4063795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-mediated behavior in rats chronically treated with (-) deprenyl.
    Gyarmati S; Timar J; Knoll B; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):667-71. PubMed ID: 2479936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.
    Kuhn DM; Wolf WA; Youdim MB
    Br J Pharmacol; 1985 Jan; 84(1):121-9. PubMed ID: 2579697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variation in the head twitch response produced by 5-methoxy-N1,N1-dimethyltryptamine and p-chloroamphetamine in the mouse.
    Singleton C; Marsden CA
    Psychopharmacology (Berl); 1981; 74(2):173-6. PubMed ID: 6168003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat brain serotonin: biochemical and functional evidence for a sex difference.
    Carlsson M; Svensson K; Eriksson E; Carlsson A
    J Neural Transm; 1985; 63(3-4):297-313. PubMed ID: 2415675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitatory and inhibitory effects of harmaline on the tryptophan-induced 5-hydroxytryptamine syndrome and body temperature changes in pargyline-pretreated rats.
    Abdel-Fattah AF; Matsumoto K; Murakami Y; El-Hady KA; Mohamed MF; Watanabe H
    Jpn J Pharmacol; 1996 Sep; 72(1):39-47. PubMed ID: 8902598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic involvement in phencyclidine-induced behaviors.
    Nabeshima T; Yamaguchi K; Hiramatsu M; Amano M; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1984 Sep; 21(3):401-8. PubMed ID: 6208563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute administration of 5-methoxy-N,N-dimethyltryptamine upon the latency and duration of post-decapitation convulsions.
    Archer T; Tandberg B
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):224-30. PubMed ID: 6239520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic involvement in pharmacological action of the anxiolytic-sedatives thalidomide and supidimide.
    Youdim MB; Ashkenazi R
    Eur J Pharmacol; 1985 Dec; 119(1-2):39-46. PubMed ID: 2867921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats.
    Kennett GA; Dickinson SL; Curzon G
    Brain Res; 1985 Mar; 330(2):253-63. PubMed ID: 4039215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
    Curzon G; Fernando JC; Marsden CA
    Br J Pharmacol; 1978 Aug; 63(4):627-34. PubMed ID: 80243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.